On June 7, 2018, the United States Patent and Trademark Office (USPTO) issued another memorandum on patent eligibility: the Vanda Memo (click here to view PDF copy). The memo is based on a recent case decided by the Federal Circuit, Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals.

{2:25 minutes to read} The new case Lexmark v. Impression addresses the right to import, reuse, and resell patented articles. Specifically, this case reaffirmed that: A seller can use its patent rights to block both resale and reuse of a product. Authorized sales of a product abroad does not exhaust the US patent rights associated […]

Buzz in the industry suggests that the United States Patent and Trademark Office (USPTO) will be doing away with the 12 factor test. In a welcome move, the buzz coming from the USPTO say that in the new “guidelines,” expected to be issued any time in the near future, will abandon the subjective “12 factors” […]